MedPath

Macrophage Markers in Periodontal and Peri-implant Health and Disease

Completed
Conditions
Periodontitis
Peri-Implantitis
Registration Number
NCT05242354
Lead Sponsor
Biruni University
Brief Summary

Macrophage surface markers (CD80, CD163 and CD206) will be evaluated in periodontally healthy gingiva, healthy peri-implant mucosa, and periodontitis and peri-implantitis lesions.

Detailed Description

Soft tissue biopsies obtained from clinically healthy gingiva, healthy peri-implant mucosa, Stage III Grade C periodontitis lesions and peri-implantitis lesions will be evaluated.

Healthy peri-implant samples are obtained from submerged implants during exposure surgery. Healthy gingiva samples are obtained from individuals receiving crown lengthening, gingivectomy or tooth extraction as excess tissue during the corresponding treatment. Samples from peri-implantitis and periodontitis (pocket depth ≥6 mm, bleeding on probing+) are obtained during initial periodontal treatment / debridement procedure with a single stroke at the pocket wall.

The samples will be grinded and ultrasonicated. Western blotting will be used for determination of CD80, CD163 and CD206 in biopsy specimens. ImageJ will be used for intensity analysis of the bands.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • diagnosed with generalized Grade C Stage III periodontitis
  • diagnosed with peri-implantitis
  • periodontally healthy individuals with dental implants in the primary healing period
  • periodontally healthy individuals who are in need of crown lengthening / gingivectomy or extraction
Exclusion Criteria
  • systemic disease
  • smoking / former smokers
  • regular medicine intake
  • antibiotic or anti-inflammatory medicine intake in the last 3 months
  • pregnancy or lactation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CD206Baseline

Tissue levels of CD206

Western Blot assay analyzed using Image J software (arbitrary density units):

Following scanning for optical densitometry, the gels were analyzed with Image J software by obtaining profile plots, drawing lines enclosing the interest area and measuring the peak area of interest with the wand tool. The calculated optical density values are presented as arbitrary density units.

CD80/CD206 RatioBaseline

Tissue levels (Western Blot assay analyzed using Image J software) of CD80 divided by those of CD206

CD80Baseline

Tissue levels of CD80

Western Blot assay analyzed using Image J software:

Following scanning for optical densitometry, the gels were analyzed with Image J software by obtaining profile plots, drawing lines enclosing the interest area and measuring the peak area of interest with the wand tool. The calculated optical density values are presented as arbitrary density units.

CD80/CD163 RatioBaseline

Tissue levels (Western Blot assay analyzed using Image J software) of CD80 divided by those of CD163

CD163Baseline

Tissue levels of CD163

Western Blot assay analyzed using Image J software:

Following scanning for optical densitometry, the gels were analyzed with Image J software by obtaining profile plots, drawing lines enclosing the interest area and measuring the peak area of interest with the wand tool. The calculated optical density values are presented as arbitrary density units.

Secondary Outcome Measures
NameTimeMethod
Probing DepthBaseline

Probing depth of each site, where the tissue sample was harvested. The average probing depth of sites in each group are presented.

Trial Locations

Locations (1)

Biruni University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath